Therefore, it appears that Notch inhibition with γ-secretase inhibitors results in a decrease in the expression of BC markers (e.g. KRT5) at the mRNA level, however there is an inverse relationship at the protein level resulting in increased levels through an unknown mechanism. Here, KRT5 is linked to breast cancer.